- Home
- RGEN vs VNO Comparison
RGEN vs VNO Comparison
Compare RGEN & VNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- VNO
- Stock Information
- Founded
- RGEN 1981
- VNO 1946
- Country
- RGEN United States
- VNO United States
- Employees
- RGEN N/A
- VNO N/A
- Industry
- RGEN Medical/Dental Instruments
- VNO Real Estate Investment Trusts
- Sector
- RGEN Health Care
- VNO Real Estate
- Exchange
- RGEN Nasdaq
- VNO Nasdaq
- Market Cap
- RGEN 8.0B
- VNO 7.0B
- IPO Year
- RGEN N/A
- VNO N/A
- Fundamental
- Price
- RGEN $123.24
- VNO $38.92
- Analyst Decision
- RGEN Buy
- VNO Hold
- Analyst Count
- RGEN 12
- VNO 11
- Target Price
- RGEN $172.67
- VNO $38.00
- AVG Volume (30 Days)
- RGEN 860.3K
- VNO 1.3M
- Earning Date
- RGEN 04-29-2025
- VNO 05-05-2025
- Dividend Yield
- RGEN N/A
- VNO 1.90%
- EPS Growth
- RGEN N/A
- VNO 248.25
- EPS
- RGEN N/A
- VNO 0.52
- Revenue
- RGEN $650,429,000.00
- VNO $1,929,890,000.00
- Revenue This Year
- RGEN $12.61
- VNO N/A
- Revenue Next Year
- RGEN $15.24
- VNO $5.02
- P/E Ratio
- RGEN N/A
- VNO $74.16
- Revenue Growth
- RGEN 4.88
- VNO 2.98
- 52 Week Low
- RGEN $102.97
- VNO $22.42
- 52 Week High
- RGEN $182.52
- VNO $46.63
- Technical
- Relative Strength Index (RSI)
- RGEN 39.31
- VNO 61.86
- Support Level
- RGEN $125.31
- VNO $36.32
- Resistance Level
- RGEN $143.56
- VNO $39.73
- Average True Range (ATR)
- RGEN 6.86
- VNO 1.25
- MACD
- RGEN -1.22
- VNO 0.57
- Stochastic Oscillator
- RGEN 0.54
- VNO 87.12
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
About VNO Vornado Realty Trust
Vornado owns and has an ownership interest in Class A office and retail properties highly concentrated in Manhattan, with additional properties in San Francisco and Chicago. It operates as a real estate investment trust.